Lin Lu
Impact in
- Clinical Biochemistry top 0.5%
- Advanced Glycation End Products research
-
- Cardiovascular Function and Risk Factors
- Cardiac Fibrosis and Remodeling
Papers in
-
- Cardiovascular Function and Risk Factors 27
- Acute Myocardial Infarction Research 11
- Co-authors
- Ruiyan Zhang (96 shared papers)Wei Feng Shen (73 shared papers)Qiujing Chen (60 shared papers)Xiao Qun Wang (35 shared papers)Ke Yang (23 shared papers)Ying Shen (45 shared papers)Jian Hu (29 shared papers)Weifeng Shen (29 shared papers)
- Journals
- Cardiovascular Diabetology (20 papers)PLoS ONE (11 papers)Atherosclerosis (9 papers)Journal of the American Heart Association (9 papers)International Journal of Cardiology (8 papers)
- Partner nations
- ChinaUnited StatesItaly
In The Last Decade
Lin Lu
181 papers receiving 4.7k citations
Lin Lu's Hit Papers
Peers
Comparison fields: 5 of 141
- Clinical Biochemistry 551
- Cardiology and Cardiovascular Medicine 1.3k
- Endocrinology, Diabetes and Metabolism 735
- Nephrology 304
- Cancer Research 545
Countries citing papers authored by Lin Lu
This map shows the geographic impact of Lin Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin Lu more than expected).
Fields of papers citing papers by Lin Lu
This network shows the impact of papers produced by Lin Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin Lu. The network helps show where Lin Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Lin Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 191 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 278 | |
| 2 | 2019 | 216 | |
| 3 | 2011 | 213 | |
| 4 | 2008 | 113 | |
| 5 | 2015 | 106 | |
| 6 | 2020 | 97 | |
| 7 | 2016 | 88 | |
| 8 | 2014 | 73 | |
| 9 | 2011 | 71 | |
| 10 | 2017 | 71 | |
| 11 | 2006 | 68 | |
| 12 | 2010 | 63 | |
| 13 | 2014 | 63 | |
| 14 | The impact of genetic variation on sensitivity to opioid analgesics in patients with postoperative pain: a systematic review and meta-analysis. | 2015 | 60 |
| 15 | 2015 | 60 | |
| 16 | 2011 | 59 | |
| 17 | 2018 | 59 | |
| 18 | 2010 | 56 | |
| 19 | Orphan Nuclear Receptor NR4A3 Promotes Vascular Calcification via Histone Lactylation Hit paper breakdown → | 2024 | 55 |
| 20 | 2009 | 54 |
About Lin Lu
Lin Lu is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology, Surgery, Endocrinology, Diabetes and Metabolism and Clinical Biochemistry, having authored 191 papers that have together received 4.8k indexed citations. Recurring topics across this work include Cardiovascular Function and Risk Factors (27 papers), Advanced Glycation End Products research (25 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (20 papers), Coronary Interventions and Diagnostics (19 papers), Cardiac Imaging and Diagnostics (15 papers), Atherosclerosis and Cardiovascular Diseases (12 papers), Adipokines, Inflammation, and Metabolic Diseases (11 papers) and Acute Myocardial Infarction Research (11 papers). The work is most often cited by research in Clinical Biochemistry (551 citations), Cardiology and Cardiovascular Medicine (1.3k citations), Endocrinology, Diabetes and Metabolism (735 citations), Nephrology (304 citations) and Cancer Research (545 citations). Lin Lu has collaborated with scholars based in China, United States and Italy. Frequent co-authors include Ruiyan Zhang, Wei Feng Shen, Qiujing Chen, Xiao Qun Wang, Ke Yang, Ying Shen, Jian Hu, Weifeng Shen, Xiaoxiang Yan and Zhili He. Their work appears in journals such as Cardiovascular Diabetology, PLoS ONE, Atherosclerosis, Journal of the American Heart Association and International Journal of Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.